Case Studies in Foreign Particulate Analysis
Download our webinar case studies on foreign particulate analysis as a critical aspect of pharmaceutical manufacturing and nonconformance investigations.
RDD 2013: Polymorph Identification of Drug Particles in Orally Inhaled and Nasal Drug Products
June 04, 2013 Authored by Oksana Olkhovyk, Ph.D., at Gateway Analytical , this poster presents new qualitative and semi-qualitative methods for the examination of size and polymorph drug particle identification in finished products. Specifically, its benefits for BA/BE testing is described using the model of fluticasone-containing nasal spray suspension formulation.…
Advancing Development of Generic OINDPs through In Vitro Testing
According to a 2007 report Measuring Trends in the Development of New Drugs: Time, Costs, Risks and Returns by J.A. DiMasi, companies spend an estimated $1.2-$1.3 billion on research…